Country Profile

Burundi

Burundi is an emerging destination for Indian pharmaceutical exports — $13.8M in FY 2025–26. Medicines accounts for 82% of shipments, with vaccines contributing $2.19M.

🇧🇮 $13.8M · 1.2× growth since FY2015 · 2.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$13.8M
Exports FY2025–26 DGCIS
1.2×
Growth FY2015→2026
2.0%
CAGR FY2015→2026
82%
Medicines Share
3
Product Categories Supplied
Burundi is an emerging destination for Indian pharmaceutical exports — $13.8M in FY 2025–26. Medicines accounts for 82% of shipments, with vaccines contributing $2.19M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $11.3M (81.7%) Vaccines $2.19M (15.9%) Surgical & Hospital Supplies $331K (2.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Burundi in the RBI overseas direct investment dataset (2011–2026).